Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
November 20, 2026 1.943
November 19, 2026 2.36
November 18, 2026 2.216
November 17, 2026 2.97
November 16, 2026 2.665
November 13, 2026 2.055
November 12, 2026 1.910
November 11, 2026 2.103
November 10, 2026 2.264
November 09, 2026 2.167
November 06, 2026 2.328
November 05, 2026 2.199
November 04, 2026 2.216
November 03, 2026 2.264
November 02, 2026 2.103
October 30, 2026 2.216
October 29, 2026 2.408
October 28, 2026 2.569
October 27, 2026 2.520
October 26, 2026 2.553
October 23, 2026 2.633
October 22, 2026 2.585
October 21, 2026 2.601
October 20, 2026 2.488
October 19, 2026 2.649
Date Value
October 16, 2026 2.874
October 15, 2026 2.793
October 14, 2026 2.745
October 13, 2026 2.810
October 12, 2026 2.938
October 09, 2026 3.114
October 08, 2026 3.131
October 07, 2026 3.420
October 06, 2026 4.399
October 05, 2026 3.885
October 02, 2026 3.708
October 01, 2026 3.355
September 30, 2026 3.307
September 29, 2026 2.874
September 28, 2026 2.729
September 25, 2026 2.681
September 24, 2026 2.761
September 23, 2026 2.697
September 22, 2026 2.729
September 21, 2026 2.681
September 18, 2026 2.665
September 17, 2026 2.392
September 16, 2026 2.376
September 15, 2026 2.376
September 14, 2026 2.440

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 16.42
Anika Therapeutics, Inc. 1.288
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.268

Price to Book Value Related Metrics

Price 1.21
Earnings Yield -213.5%
Market Cap 21.28M